Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | %Female (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 1 | 9 | 299 | 2 | 9 | 0.33 | 299.00 | 57.14 | ||
2 | Drug Resistance Updates | journal | 3.920 Q1 | 132 | 17 | 66 | 3750 | 944 | 66 | 11.09 | 220.59 | 56.94 | |
3 | Advances in Cancer Research | journal | 0.893 Q2 | 109 | 30 | 104 | 5564 | 562 | 13 | 5.10 | 185.47 | 0.00 | |
4 | Biochimica et Biophysica Acta - Reviews on Cancer | journal | 2.824 Q1 | 159 | 65 | 184 | 9717 | 1420 | 181 | 7.64 | 149.49 | 36.77 | |
5 | Annual Review of Cancer Biology | book series | 36 | 23 | 47 | 3110 | 274 | 46 | 5.83 | 135.22 | 27.27 | ||
6 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 2 | 10 | 257 | 0 | 10 | 0.00 | 128.50 | 48.48 | ||
7 | Blood Reviews | journal | 2.049 Q1 | 112 | 56 | 144 | 6512 | 878 | 144 | 6.08 | 116.29 | 37.78 | |
8 | Cancer and Metastasis Reviews | journal | 2.810 Q1 | 167 | 60 | 160 | 6916 | 1153 | 154 | 5.96 | 115.27 | 42.04 | |
9 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.603 Q3 | 52 | 29 | 94 | 2940 | 250 | 91 | 2.75 | 101.38 | 44.35 | |
10 | Cancer Treatment and Research | journal | 0.191 Q4 | 65 | 58 | 117 | 5358 | 192 | 20 | 0.98 | 92.38 | 0.00 | |
11 | Cancer Microenvironment | journal | 0.877 Q2 | 51 | 16 | 40 | 1472 | 117 | 39 | 2.52 | 92.00 | 50.60 | |
12 | Experientia supplementum (2012) | journal | 0.177 | 11 | 21 | 33 | 1797 | 18 | 33 | 0.55 | 85.57 | 0.00 | |
13 | Expert Review of Anticancer Therapy | journal | 0.959 Q2 | 85 | 101 | 391 | 8621 | 1096 | 341 | 3.25 | 85.36 | 31.88 | |
14 | Ca-A Cancer Journal for Clinicians | journal | 88.192 Q1 | 211 | 35 | 125 | 2924 | 18020 | 88 | 112.67 | 83.54 | 49.10 | |
15 | Journal of Hematology and Oncology | journal | 3.231 Q1 | 144 | 135 | 433 | 11212 | 4026 | 426 | 10.29 | 83.05 | 40.64 | |
16 | Cancer Treatment Reviews | journal | 3.619 Q1 | 164 | 70 | 385 | 5772 | 3590 | 379 | 9.21 | 82.46 | 44.91 | |
17 | Critical Reviews in Oncology/Hematology | journal | 2.213 Q1 | 144 | 191 | 603 | 15561 | 3611 | 602 | 6.26 | 81.47 | 44.19 | |
18 | Molecular Cancer | journal | 4.581 Q1 | 196 | 158 | 409 | 12689 | 5911 | 375 | 15.19 | 80.31 | 39.18 | |
19 | Journal of Mammary Gland Biology and Neoplasia | journal | 0.959 Q2 | 112 | 27 | 58 | 2159 | 173 | 56 | 3.21 | 79.96 | 52.89 | |
20 | Current Cancer Drug Targets | journal | 0.893 Q2 | 103 | 81 | 240 | 6341 | 652 | 219 | 2.62 | 78.28 | 42.96 | |
21 | Cancers | journal | 1.938 Q1 | 133 | 2030 | 802 | 158844 | 5027 | 780 | 6.20 | 78.25 | 44.88 | |
22 | Journal of the National Cancer Institute. Monographs | journal | 0.875 Q2 | 95 | 23 | 17 | 1798 | 73 | 17 | 4.29 | 78.17 | 47.62 | |
23 | Journal of Cancer Metastasis and Treatment | journal | 16 | 79 | 0 | 6131 | 0 | 0 | 0.00 | 77.61 | 44.31 | ||
24 | Gastric and Breast Cancer | journal | 0.111 Q4 | 6 | 13 | 21 | 1005 | 1 | 21 | 0.05 | 77.31 | 47.06 | |
25 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 13 | 11 | 10 | 847 | 48 | 9 | 4.80 | 77.00 | 62.07 | ||
26 | Endocrine-Related Cancer | journal | 1.545 Q1 | 146 | 102 | 430 | 7826 | 1874 | 391 | 4.22 | 76.73 | 45.73 | |
27 | Annals of Pancreatic Cancer | journal | 7 | 20 | 32 | 1474 | 9 | 18 | 0.28 | 73.70 | 38.37 | ||
28 | Cancer Nanotechnology | journal | 1.299 Q2 | 36 | 11 | 32 | 781 | 199 | 29 | 5.00 | 71.00 | 46.94 | |
29 | Cellular oncology (Dordrecht) | journal | 1.271 Q2 | 58 | 59 | 155 | 4110 | 749 | 152 | 5.04 | 69.66 | 37.34 | |
30 | Current Oncology Reports | journal | 1.490 Q1 | 77 | 112 | 260 | 7727 | 1059 | 259 | 4.01 | 68.99 | 41.96 | |
31 | Gastrointestinal Disorders | journal | 8 | 32 | 0 | 2189 | 0 | 0 | 0.00 | 68.41 | 34.55 | ||
32 | Oncology Reviews | journal | 1.703 Q1 | 31 | 24 | 36 | 1638 | 207 | 35 | 6.14 | 68.25 | 32.18 | |
33 | Biologics: Targets and Therapy | journal | 0.697 Q3 | 47 | 17 | 50 | 1157 | 150 | 50 | 2.84 | 68.06 | 35.38 | |
34 | Immuno-Oncology and Technology | journal | 10 | 13 | 0 | 879 | 0 | 0 | 0.00 | 67.62 | 36.36 | ||
35 | Trends in Cancer | journal | 3.961 Q1 | 90 | 90 | 279 | 6044 | 2103 | 265 | 7.32 | 67.16 | 41.43 | |
36 | Current Hematologic Malignancy Reports | journal | 0.980 Q2 | 44 | 63 | 194 | 4228 | 548 | 192 | 2.76 | 67.11 | 42.35 | |
37 | Current Treatment Options in Oncology | journal | 1.310 Q2 | 66 | 87 | 220 | 5657 | 878 | 218 | 4.03 | 65.02 | 34.05 | |
38 | Seminars in Radiation Oncology | journal | 1.202 Q2 | 103 | 42 | 131 | 2656 | 405 | 119 | 3.91 | 63.24 | 37.09 | |
39 | Seminars in Oncology | journal | 1.773 Q1 | 145 | 55 | 191 | 3347 | 724 | 162 | 3.61 | 60.85 | 38.56 | |
40 | Therapeutic Advances in Medical Oncology | journal | 2.304 Q1 | 68 | 111 | 171 | 6724 | 1082 | 157 | 6.38 | 60.58 | 40.30 | |
41 | Journal of Oncology (discontinued) | journal | 0.937 Q2 | 68 | 236 | 82 | 14294 | 217 | 82 | 2.41 | 60.57 | 43.11 | |
42 | Hepatoma Research | journal | 14 | 43 | 0 | 2599 | 0 | 0 | 0.00 | 60.44 | 31.85 | ||
43 | Frontiers in Oncology | journal | 1.654 Q1 | 136 | 1409 | 1235 | 84265 | 5880 | 1168 | 4.88 | 59.80 | 41.57 | |
44 | npj Precision Oncology | journal | 36 | 33 | 28 | 1965 | 151 | 27 | 5.39 | 59.55 | 41.26 | ||
45 | Cancer Reports | journal | 18 | 62 | 20 | 3690 | 7 | 19 | 0.35 | 59.52 | 43.62 | ||
46 | Current Cancer Therapy Reviews | journal | 0.128 Q4 | 17 | 25 | 47 | 1482 | 11 | 38 | 0.35 | 59.28 | 46.43 | |
47 | Cancer Letters | journal | 2.356 Q1 | 216 | 420 | 1467 | 24653 | 10499 | 1449 | 6.97 | 58.70 | 40.38 | |
48 | Cancer journal (Sudbury, Mass.) | journal | 1.491 Q1 | 102 | 69 | 182 | 4022 | 531 | 161 | 3.07 | 58.29 | 46.03 | |
49 | Nature Reviews Cancer | journal | 21.287 Q1 | 505 | 132 | 345 | 7563 | 8499 | 203 | 22.27 | 57.30 | 35.38 | |
50 | Cancer Biology and Medicine | journal | 1.927 Q1 | 62 | 71 | 140 | 4054 | 773 | 140 | 5.45 | 57.10 | 45.01 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®